Concepedia

Additive antiemetic efficacy of low-doses of the cannabinoid CB1/2 receptor agonist Δ9-THC with ultralow-doses of the vanilloid TRPV1 receptor agonist resiniferatoxin in the least shrew (Cryptotis parva)

Nissar A. Darmani, Seetha Chebolu, Weixia Zhong, Chung Trinh, Bryan McClanahan, Rajivinder Singh Brar

European Journal of Pharmacology · 2013 · 23 citations · 28 references

DOI

Concepts

References

28

Chemistry, metabolism, and toxicology of cannabis: clinical implications.

Priyamvada Sharma, Pratima Murthy, M. M. Srinivas Bharath · PubMed · 2012 · 276 citations · Full text

, , +14

Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting

Eyal Meiri, Haresh Jhangiani, James J. Vredenburgh et al. · Current Medical Research and Opinion · 2007 · 213 citations

, , +17

An efficient new cannabinoid antiemetic in pediatric oncology

Aya Abrahamov, Avraham Abrahamov, Raphael Mechoulam · Life Sciences · 1995 · 184 citations

, , +11

Δ<sup>9</sup>-Tetrahydrocannabinol selectively acts on CB<sub>1</sub> receptors in specific regions of dorsal vagal complex to inhibit emesis in ferrets

Marja D. Van Sickle, Lorraine D. Oland, Ken Mackie et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 2003 · 139 citations

, , +14

A comparative analysis of the potential of cannabinoids and ondansetron to suppress cisplatin-induced emesis in the Suncus murinus (house musk shrew)

Magdalena Kwiatkowska, LindaA. Parker, Page Burton et al. · Psychopharmacology · 2004 · 131 citations

, , +8